GlobeNewswire: Merit Medical Systems, Inc. Contains the last 10 of 391 releaseshttp://www.globenewswire.com/External?Length=42024-03-30T03:44:09ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/19/2848662/0/en/Merit-Medical-Launches-the-Micro-ACE-Advanced-Micro-Access-System.html?f=22&fvtc=4&fvtv=6203Merit Medical Launches the Micro ACE™ Advanced Micro-Access System2024-03-19T13:25:00Z<![CDATA[Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases]]>https://www.globenewswire.com/news-release/2024/03/18/2848211/0/en/Merit-Medical-Systems-to-Announce-First-Quarter-2024-Results-on-April-30-2024.html?f=22&fvtc=4&fvtv=6203Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 20242024-03-18T21:19:29Z<![CDATA[SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2024, after the close of the stock market on Tuesday, April 30, 2024.]]>https://www.globenewswire.com/news-release/2024/03/05/2840568/0/en/Merit-Medical-to-Host-Evening-of-Innovation-during-the-2024-Society-of-Interventional-Radiology-SIR-Annual-Scientific-Meeting.html?f=22&fvtc=4&fvtv=6203Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting2024-03-05T14:25:00Z<![CDATA[Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320 Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320]]>https://www.globenewswire.com/news-release/2024/02/28/2837420/0/en/Merit-Medical-Introduces-Continued-Growth-Initiatives-Program-and-Financial-Targets-for-Three-Year-Period-Ending-December-31-2026.html?f=22&fvtc=4&fvtv=6203Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026 2024-02-28T21:05:00Z<![CDATA[SOUTH JORDAN, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today introduced its Continued Growth Initiatives Program and related financial targets for the three-year period ending December 31, 2026.]]>https://www.globenewswire.com/news-release/2024/02/28/2837425/0/en/Merit-Medical-Reports-Results-For-Fourth-Quarter-and-Year-Ended-December-31-2023-Issues-Fiscal-Year-2024-Guidance.html?f=22&fvtc=4&fvtv=6203Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance2024-02-28T21:05:00Z<![CDATA[* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.]]>https://www.globenewswire.com/news-release/2024/02/15/2830060/0/en/Merit-Medical-Receives-FDA-510-k-Clearance-for-SCOUT-MD-Surgical-Guidance-System.html?f=22&fvtc=4&fvtv=6203Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System2024-02-15T14:25:00Z<![CDATA[New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries]]>https://www.globenewswire.com/news-release/2024/01/16/2810316/0/en/First-Patient-Enrolled-in-Merit-Medical-s-MOTION-Study.html?f=22&fvtc=4&fvtv=6203First Patient Enrolled in Merit Medical’s MOTION Study2024-01-16T21:05:00Z<![CDATA[SOUTH JORDAN, Utah, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the successful enrollment of the first patient in its multicenter, prospective, randomized, controlled trial comparing genicular artery embolization (GAE) using Embosphere® Microspheres to corticosteroid injections for the treatment of symptomatic knee osteoarthritis (MOTION) study.]]>https://www.globenewswire.com/news-release/2024/01/08/2805512/0/en/Merit-Medical-Announces-Projected-Preliminary-Unaudited-Revenue-for-the-Year-Ended-December-31-2023-and-Plans-to-Announce-Fourth-Quarter-and-Year-End-2023-Results-and-Issue-Fiscal-.html?f=22&fvtc=4&fvtv=6203Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 20242024-01-08T14:00:00Z<![CDATA[* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP Financial Measure” below.]]>https://www.globenewswire.com/news-release/2024/01/03/2803619/0/en/Merit-Medical-to-Present-at-the-J-P-Morgan-42nd-Annual-Healthcare-Conference.html?f=22&fvtc=4&fvtv=6203Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference2024-01-03T21:05:00Z<![CDATA[Merit Medical Chairman and CEO Fred Lampropoulos to present on Monday, January 8 Merit Medical Chairman and CEO Fred Lampropoulos to present on Monday, January 8]]>https://www.globenewswire.com/news-release/2023/12/18/2798128/0/en/Merit-Medical-Announces-Process-for-Chief-Executive-Officer-Succession-Planning.html?f=22&fvtc=4&fvtv=6203Merit Medical Announces Process for Chief Executive Officer Succession Planning2023-12-18T21:05:00Z<![CDATA[SOUTH JORDAN, Utah, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today outlined the ongoing succession planning process for its Chief Executive Officer (CEO). Pursuant to an Amended and Restated Employment Agreement, effective June 8, 2023, Merit founder, CEO, and President, Fred Lampropoulos, will continue to serve as Merit’s CEO and President through December 31, 2025.]]>